M&A - a buyer’s market
This article was originally published in Clinica
Executive Summary
GE Healthcare’s recently announced $580m purchase of cancer diagnostics firm Clarient, its first all-out acquisition in the IVD sector, brings to an end a busy few months for M&A activity, as seen in Clinica’s 2010 M&A table (www.clinica.co.uk/mna).